August 2024 - Defence Therapeutics

Defence Investigates The Application Of The Accum® Hydrogel Technology To Deliver Glp-1 In Order To Increase The Treatment Efficacy Of Diabetes And Weight Loss

by FiveSenses | Aug 26, 2024 | News Release

Vancouver, BC, Canada, August 19th, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to...

Defence Therapeutics Collaboration Agreement With Orano To Develop The Next Generation Of Targeted Radio-Immunotherapy For Cancer Advances

by FiveSenses | Aug 13, 2024 | News Release

Vancouver, BC, Canada, August 13th, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to...

Defence Investigates The Application Of The Accum® Hydrogel Technology To Deliver Glp-1 In Order To Increase The Treatment Efficacy Of Diabetes And Weight Loss

Defence Therapeutics Collaboration Agreement With Orano To Develop The Next Generation Of Targeted Radio-Immunotherapy For Cancer Advances

Recent Posts

Recent Comments

Archives

Categories

Meta

Connect with us:
Sign up for news and investor alerts.